# Antidepressants During Pregnancy Not Linked to Autism, ADHD
New research provides reassurance for pregnant people taking antidepressants. A large study found no connection between prenatal antidepressant use and autism spectrum disorder or ADHD in children.
The findings matter because many pregnant people face a difficult choice. Untreated depression and anxiety during pregnancy carry real risks, including premature birth and low birth weight. Yet concern about medication effects on the developing fetus has led some to stop treatment.
This research confirms what growing evidence suggests. Taking selective serotonin reuptake inhibitors (SSRIs) like sertraline, paroxetine, or fluoxetine during pregnancy does not increase autism or ADHD risk in offspring. The study examined large population data to reach this conclusion, strengthening confidence in the results.
Mental health matters before, during, and after pregnancy. Depression and anxiety during pregnancy affect both parent and baby. Untreated conditions can worsen postpartum depression, which impacts parenting capacity and family bonding. The stress hormones released during untreated mental illness cross the placenta and affect fetal development.
For pregnant people already taking antidepressants, the message is clear. Stopping medication abruptly carries its own risks. Withdrawal symptoms and relapse can occur, destabilizing mental health precisely when support is needed most.
The takeaway for families planning pregnancy or currently pregnant: talk openly with your obstetrician and mental health provider about medication. Together, you can weigh the benefits of continuing treatment against any concerns. This conversation belongs to you and your doctors, not to fear or outdated information.
Pregnancy involves many health decisions. Mental health care is healthcare. Taking an antidepressant when you need it protects both your wellbeing and your baby's development. This